Gates Foundation Blog Examines New Vaccine Discovery Partnership

In a post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Trevor Mundel, president of global health at the foundation, examines the Vaccine Discovery Partnership, “a new initiative that will lead to better and more effective approaches to vaccine research and development.” The new effort “will be a way for our foundation to work directly with pharmaceutical companies on promising new vaccines for global health,” he states, adding, “We will work with each company individually to identify a promising set of research projects that are aligned with our foundation’s priorities.” Mundel notes, “GlaxoSmithKline (GSK) and Sanofi are the first two companies with whom we’ve signed agreements” (10/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.